Cornercap Investment Counsel’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,611
Closed -$939K 671
2022
Q4
$939K Buy
25,611
+9,041
+55% +$357K 0.16% 259
2022
Q3
$781K Buy
+16,570
New +$1.07M 0.15% 301
2017
Q1
Sell
-32,804
Closed -$1.73M 402
2016
Q4
$1.73M Sell
32,804
-395
-1% -$19.1K 0.3% 102
2016
Q3
$1.48M Buy
33,199
+390
+1% +$16.9K 0.27% 98
2016
Q2
$1.25M Sell
32,809
-1,535
-4% -$67.4K 0.24% 100
2016
Q1
$1.42M Buy
34,344
+7,680
+29% +$317K 0.27% 74
2015
Q4
$1.29M Buy
26,664
+12,390
+87% +$551K 0.25% 74
2015
Q3
$571K Sell
14,274
-120
-0.8% -$5.24K 0.11% 102
2015
Q2
$577K Buy
+14,394
New +$497K 0.1% 108

Other funds holding SYNH

Cornercap Investment Counsel's SYNH Position: Q1 2023 in Review

Cornercap Investment Counsel sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 25,611 shares — an estimated $939K sold.

Cornercap Investment Counsel first reported a position in SYNH in Q2 2015 and held it in 9 quarters. The position peaked at $1.73M in Q4 2016. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Cornercap Investment Counsel reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 25,611 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $939K.
  • Cornercap Investment Counsel first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 9 quarters.
  • Cornercap Investment Counsel's Syneos Health, Inc. Class A Common Stock position peaked at $1.73M in Q4 2016.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Cornercap Investment Counsel's 13F filing for Q1 2023, filed 11 May 2023.